Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Brem

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Nature Communications|August 29, 2018
PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastomaTianrun Liu, Wenjuan Ma, Haineng Xu, et al.
Journal of Neuro-Oncology|November 18, 2018
Histopathologic quantification of viable tumor versus treatment effect in surgically resected recurrent glioblastomaStephen J Bagley, Robert D Schwab, Ernest Nelson, et al.
Neuro-Oncology Practice|March 25, 2020
<sup>18</sup>F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical samplingFraser Henderson, Steven Brem, Donald M O'Rourke, et al.
Neuro-Oncology Advances|November 6, 2024
Distinction of pseudoprogression from true progression in glioblastomas using machine learning based on multiparametric magnetic resonance imaging and O<sup>6</sup>-methylguanine-methyltransferase promoter methylation statusVirendra Kumar Yadav, Suyash Mohan, Sumeet Agarwal, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 18, 2026
Management strategies and clinical outcomes for thalamic neuroepithelial cysts: 10-year single center experienceSami Almasri, Om H Gandhi, Katherine L Wei, et al.
Cancer Research|May 20, 2004
Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptorJiazhi Sun, Michelle A Blaskovich, Rishi K Jain, et al.
Neuro-Oncology Advances|August 9, 2023
Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastomaTimothy E Richardson, Raquel T Yokoda, Omid Rashidipour, et al.
Journal of Neuro-Oncology|September 23, 2019
Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastomaDaniel I Hoffman, Kalil G Abdullah, Makayla McCoskey, et al.
Radiation Oncology (London, England)|November 2, 2015
Intracranial control after Cyberknife radiosurgery to the resection bed for large brain metastasesJennifer Vogel, Eric Ojerholm, Andrew Hollander, et al.
Journal of Neuro-Oncology|January 5, 2011
Cancer susceptibility variants and the risk of adult glioma in a US case-control studyKathleen M Egan, Reid C Thompson, L B Nabors, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Nature Communications|August 29, 2018
PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastomaTianrun Liu, Wenjuan Ma, Haineng Xu, et al.
Journal of Neuro-Oncology|November 18, 2018
Histopathologic quantification of viable tumor versus treatment effect in surgically resected recurrent glioblastomaStephen J Bagley, Robert D Schwab, Ernest Nelson, et al.
Neuro-Oncology Practice|March 25, 2020
<sup>18</sup>F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical samplingFraser Henderson, Steven Brem, Donald M O'Rourke, et al.
Neuro-Oncology Advances|November 6, 2024
Distinction of pseudoprogression from true progression in glioblastomas using machine learning based on multiparametric magnetic resonance imaging and O<sup>6</sup>-methylguanine-methyltransferase promoter methylation statusVirendra Kumar Yadav, Suyash Mohan, Sumeet Agarwal, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 18, 2026
Management strategies and clinical outcomes for thalamic neuroepithelial cysts: 10-year single center experienceSami Almasri, Om H Gandhi, Katherine L Wei, et al.
Cancer Research|May 20, 2004
Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptorJiazhi Sun, Michelle A Blaskovich, Rishi K Jain, et al.
Neuro-Oncology Advances|August 9, 2023
Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastomaTimothy E Richardson, Raquel T Yokoda, Omid Rashidipour, et al.
Journal of Neuro-Oncology|September 23, 2019
Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastomaDaniel I Hoffman, Kalil G Abdullah, Makayla McCoskey, et al.
Radiation Oncology (London, England)|November 2, 2015
Intracranial control after Cyberknife radiosurgery to the resection bed for large brain metastasesJennifer Vogel, Eric Ojerholm, Andrew Hollander, et al.
Journal of Neuro-Oncology|January 5, 2011
Cancer susceptibility variants and the risk of adult glioma in a US case-control studyKathleen M Egan, Reid C Thompson, L B Nabors, et al.
Pageof 13